Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Enosse, Sonia ^a,b   Magnussen, Pascal ^c   Abacassamo, Fatima ^b   Gómez Olivé, Xavier ^b,d   Rønn, Anita M ^c,e   Thompson, Ricardo ^a,b   Alifrangis, Michael ^c,e  

^a INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^b Ministério de Saúde   (Mozambique)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FANSIDAR; ANTIMALARIAL AGENT; CARRIER PROTEIN; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM CRT GENE; PLASMODIUM FALCIPARUM DHFR GENE; PLASMODIUM FALCIPARUM DHPS GENE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; ANIMAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENE FREQUENCY; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; METHODOLOGY; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; HAPLOTYPES; HUMANS; INFANT; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MOZAMBIQUE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 47749144814     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-115     Document Type: Article

References (23)

1. Antimalarial drug resistance and combination chemotherapy. N White, Philos Trans R Soc Lond B Biol Sci 1999 354 739 749 10365399 10.1098/rstb.1999.0426
2. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 1474 1480 10.1016/S0140-6736(05)66417-3 15850631
3. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. CE Rwagacondo F Niyitegeka J Sarushi C Karema V Mugisha JC Dujardin C Van Overmeir EJ van den U D'Alessandro, Am J Trop Med Hyg 2003 68 743 747 12887037
4. Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy! TK Mutabingwa, Acta Trop 2005 95 305 315 10.1016/j.actatropica.2005.06.009 16098946
5. Normas de Manejo de casos de malária em Mozambique. Miniserio da Saude, Programa Nacional de Controlo da Malaria. A Tiago F Saute, Miniserio da Saude, Programa Nacional de Controlo da Malaria 2005
6. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. F Abacassamo S Enosse JJ Aponte FX Gomez-Olive L Quinto S Mabunda A Barreto P Magnussen AM Ronn R Thompson PL Alonso, Trop Med Int Health 2004 9 200 208 10.1046/j.1365-3156.2003.01182.x 15040556
7. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M Dgedge P Alonso C Menendez, J Infect Dis 2006 194 276 285 10.1086/505431 16826474
8. Intermittent preventive treatment of malaria during pregnancy in central Mozambique. PE Brentlinger M Dgedge MA Correia AJ Rojas F Saute KH Gimbel-Sherr BA Stubbs MA Mercer S Gloyd, Bull World Health Organ 2007 85 873 879 18038078
9. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. D Kyabayinze A Cattamanchi MR Kamya PJ Rosenthal G Dorsey, Am J Trop Med Hyg 2003 69 247 252 14628939
10. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
11. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. D Francis SL Nsobya A Talisuna A Yeka MR Kamya R Machekano C Dokomajilar PJ Rosenthal G Dorsey, J Infect Dis 2006 193 978 986 10.1086/500951 16518760
12. Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum. A Enevold WM Nkya M Theisen LS Vestergaard AT Jensen T Staalsoe TG Theander IC Bygbjerg M Alifrangis, Malar J 2007 6 153 18021388 10.1186/1475-2875-6-153
13. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. G Holmgren JP Gil PM Ferreira MI Veiga CO Obonyo A Bjorkman, Infect Genet Evol 2005 16271310
14. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. CT Happi GO Gbotosho OA Folarin OM Bolaji A Sowunmi DE Kyle W Milhous DF Wirth AM Oduola, Am J Trop Med Hyg 2006 75 155 161 16837724
15. Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. DC Warhurst, Malar J 2003 2 31 14599295 10.1186/1475-2875-2-31
16. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. M Alifrangis MB Dalgaard JP Lusingu LS Vestergaard T Staalsoe AT Jensen A enevold AM Ronn IF Khalil DC Warhurst MM Lemnge TG Theander IC Bygbjerg, J Infect Dis 2006 193 1738 1741 10.1086/504269 16703518
17. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant. N Fernandes P Figueiredo R do V P Cravo, Malar J 2007 6 35 17378942 10.1186/1475-2875-6-35
18. Differential Effect of Regional Drug Pressure on Dihydrofolate Reductase and Dihydropteroate Synthetase Mutations in Southern Mozambique. J Raman B Sharp I Kleinschmidt C Roper E Streat V Kelly KI Barnes, Am J Trop Med Hyg 2008 78 256 261 18256426
19. Antimalarial drug resistance in southern Mozambique: treatment efficacy and molecular characterization of Plasmodium falcipraum resistnace to sulfadoxine-pyrimethamine. SMM Enosse, Instituto Nacional de Saúde; Ministério da Saude, Maputo, Mozambique. Danish Bilharziasis Laboratory, Denmark 2004 15040556
20. A simple high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum cloroquine resistance transporter genes using ploymerase chain reaction and enzyme linked immunosorbent assay-based technology. M Alifrangis S Enosse R Pearce C Drakeley C Roper IF Khalil WM Nkya AM Ronn TG Theander IC Bygbjerg, Am J Trop Med Hyg 2005 72 155 162 15741552
21. Prediction of Plasmodium falciparum resistance to sulfadoxine/ pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity. M Alifrangis S Enosse IF Khalil DS Tarimo MM Lemnge R Thompson IC Bygbjerg AM Ronn, Am J Trop Med Hyg 2003 69 601 606 14740875
22. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. I Khalil AM Ronn M Alifrangis HA Gabar GM Satti IC Bygbjerg, Am J Trop Med Hyg 2003 68 586 589 12812351
23. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkamp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03) 12951-0 12686039